» Articles » PMID: 35296465

Waiting for the Truth: is Reluctance in Accepting an Early Origin Hypothesis for SARS-CoV-2 Delaying Our Understanding of Viral Emergence?

Abstract

Two years after the start of the COVID-19 pandemic, key questions about the emergence of its aetiological agent (SARS-CoV-2) remain a matter of considerable debate. Identifying when SARS-CoV-2 began spreading among people is one of those questions. Although the current canonically accepted timeline hypothesises viral emergence in Wuhan, China, in November or December 2019, a growing body of diverse studies provides evidence that the virus may have been spreading worldwide weeks, or even months, prior to that time. However, the hypothesis of earlier SARS-CoV-2 circulation is often dismissed with prejudicial scepticism and experimental studies pointing to early origins are frequently and speculatively attributed to false-positive tests. In this paper, we critically review current evidence that SARS-CoV-2 had been circulating prior to December of 2019, and emphasise how, despite some scientific limitations, this hypothesis should no longer be ignored and considered sufficient to warrant further larger-scale studies to determine its veracity.

Citing Articles

Pre-pandemic antibodies screening against SARS-CoV-2 and virus detection among children diagnosed with eruptive fevers.

Najimi N, Tajount L, Regragui Z, Remz C, Ait-Lhaj-Mhand R, Kadi C Int J Immunopathol Pharmacol. 2024; 38:3946320241260633.

PMID: 38836458 PMC: 11155355. DOI: 10.1177/03946320241260633.


Features of SARS-CoV-2 Replication in Various Types of Reptilian and Fish Cell Cultures.

Kononova Y, Adamenko L, Kazachkova E, Solomatina M, Romanenko S, Proskuryakova A Viruses. 2023; 15(12).

PMID: 38140591 PMC: 10748073. DOI: 10.3390/v15122350.


The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic.

Canuti M, Monti M, Bobbio C, Muscatello A, Muheberimana T, Baldi S Front Med (Lausanne). 2023; 10:1260950.

PMID: 37746083 PMC: 10513414. DOI: 10.3389/fmed.2023.1260950.


Can Some Viral Respiratory Infections Observed Before the Pandemic Announcement Be Related to SARS-CoV-2?.

Alpaydin A, Appak O, Gezer N, Yigit S, Gunduz Karayazi D, Kuruuzum Z Thorac Res Pract. 2023; 24(2):91-95.

PMID: 37503645 PMC: 10652072. DOI: 10.5152/ThoracResPract.2023.22187.


Serological investigation of SARS-CoV-2 infection in patients with suspect measles, 2017-2022.

Bianchi S, Fappani C, Gori M, Canuti M, Colzani D, Monti M Virol J. 2023; 20(1):160.

PMID: 37474969 PMC: 10357797. DOI: 10.1186/s12985-023-02117-9.


References
1.
Riccardo F, Ajelli M, Andrianou X, Bella A, Del Manso M, Fabiani M . Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020. Euro Surveill. 2020; 25(49). PMC: 7730489. DOI: 10.2807/1560-7917.ES.2020.25.49.2000790. View

2.
Amendola A, Bianchi S, Gori M, Colzani D, Canuti M, Borghi E . Evidence of SARS-CoV-2 RNA in an Oropharyngeal Swab Specimen, Milan, Italy, Early December 2019. Emerg Infect Dis. 2020; 27(2):648-650. PMC: 7853584. DOI: 10.3201/eid2702.204632. View

3.
La Rosa G, Mancini P, Bonanno Ferraro G, Veneri C, Iaconelli M, Bonadonna L . SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoring. Sci Total Environ. 2020; 750:141711. PMC: 7428442. DOI: 10.1016/j.scitotenv.2020.141711. View

4.
Zehender G, Lai A, Bergna A, Meroni L, Riva A, Balotta C . Genomic characterization and phylogenetic analysis of SARS-COV-2 in Italy. J Med Virol. 2020; 92(9):1637-1640. PMC: 7228393. DOI: 10.1002/jmv.25794. View

5.
Tian D, Sun Y, Zhou J, Ye Q . The global epidemic of SARS-CoV-2 variants and their mutational immune escape. J Med Virol. 2021; 94(3):847-857. PMC: 8661756. DOI: 10.1002/jmv.27376. View